HOME >> BIOLOGY >> NEWS
ACS Weekly PressPac -- September 6, 2006

ies of 11 percent, whereas most new solar cells have efficiencies between 4 percent and 5 percent, according to Michael Graetzel, Ph.D., a chemist at the Swiss Federal Institute of Technology, Lausanne.

Graetzel's cells, which can be engineered into inexpensive, flexible sheets, could be used as coatings on glass windows to supply electric power to homes and businesses or as coatings on tents to supply power for soldiers in the field. The cells could be used in consumer applications within two to three years, the researcher says.

CONTACT: Michael Graetzel, Ph.D.
Swiss Federal Institute of Technology
Switzerland
Phone: 41-21-693-3112
Fax: 41-21-693-4111
e-mail: Michael.graetzel@epfl.ch


ARTICLE #3 EMBARGOED FOR: Sunday, Sept. 10, 5:30 p.m., EDT
'Conversation stoppers' fight deadly bacterial infections

NOTE: A press conference on this topic with call-in audio participation will be held at 10 a.m. Sept. 11. Reporters are asked to call five to ten minutes prior to the scheduled start time. Reporters will be asked to identify themselves, their affiliations and the topic of the briefing. Call 800-967-7140 (domestic); 719-457-2629 (international).

Bacterial infections are becoming more deadly worldwide due to increased resistance to antibiotics. Now Helen E. Blackwell and colleagues have developed a powerful strategy to fight these deadly infections: Instead of killing the bacteria directly, the scientists designed a group of compounds that can block the chemical signals that the bacteria use to communicate in an effort to stop their spread.

These compounds, small organic molecules that they call 'conversation stoppers,' could help deliver a powerful one-two punch to knock out deadly infections when combined with the killing power of antibiotics. In addition, these 'conversation stoppers' do not target bac
'"/>

Contact: Michael Woods
m_woods@acs.org
American Chemical Society
12-Sep-2006


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
3. American Chemical Societys Weekly PressPac -- July 25, 2007
4. American Chemical Societys Weekly PressPac -- July 18, 2007
5. American Chemical Societys Weekly PressPac -- July 11, 2007
6. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
7. American Chemical Societys Weekly PressPac -- June 20, 2007
8. American Chemical Societys Weekly PressPac -- June 13, 2007
9. American Chemical Societys Weekly PressPac -- May 30, 2007
10. ACS News Service Weekly PressPac -- May 23, 2007
11. ACS News Service Weekly PressPac -- May 16, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we spend ... recovery so we need to do it well. Inadequate sleep levels have been found ... pressure, stroke, diabetes, and even cancer. Maybe now is the best time ... could help them to manage their sleep quality? Continue ... ...
(Date:11/29/2016)... -- BioDirection, a privately held medical device company developing ... of concussion and other traumatic brain injury (TBI), announced ... with the U.S. Food and Drug Administration (FDA) to ... the meeting company representatives reviewed plans for clinical development ... of a planned pilot trial. "We ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 01, 2016 , ... ACEA Biosciences, ... its Phase I/II clinical trials for AC0010 at the World Conference on Lung Cancer ... providing an update on the phase I/II clinical trials for AC0010 in patients with ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only way to ... technology experience. All three tenets were on display at the 2nd Annual DrugDev User ... 40 sponsor, CRO and site organizations to discuss innovation and the future of clinical ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... Nov. 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" ... PBT.U), is excited to announce the formation of ... developing preclinical ophthalmology assets through proof of concept. ... created by Portage Pharmaceuticals Limited and being developed ... surface and anterior segment diseases. This agent has ...
Breaking Biology Technology:
Cached News: